Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Singh

Showing results (121-130 of 3,153) with videos related to

Pageof 316
Sort By:
F1000Research|April 15, 2014
Use of botulinum toxin in musculoskeletal painJasvinder A Singh
Arthritis Research & Therapy|April 1, 2014
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative studyJasvinder A Singh
Annals of the Rheumatic Diseases|January 22, 2015
When gout goes to the heart: does gout equal a cardiovascular disease risk factor?Jasvinder A Singh
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 4, 2020
COVID-19: Science and global health governance under attackJ A Singh
Rheumatology Advances in Practice|January 14, 2022
Disease modification in gout: a qualitative study of gout expert rheumatologistsJasvinder A Singh
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 12, 2021
Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, or Low Back Pain: A National US StudyJasvinder A Singh
Osteoarthritis and Cartilage|November 9, 2023
Does the money matter? Disparities in total joint replacement outcomes by incomeJasvinder A Singh
Annals of the Rheumatic Diseases|July 4, 2020
Response to: 'Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland' by Quills <i>et al</i>Jasvinder A Singh
Expert Opinion on Emerging Drugs|November 7, 2012
Emerging therapies for goutJasvinder A Singh
Rheumatic Diseases Clinics of North America|August 11, 2022
Treatment Guidelines in Rheumatoid ArthritisJasvinder A Singh
Pageof 316

Showing results (121-130 of 3,153) with videos related to

Sort By:
Pageof 316
F1000Research|April 15, 2014
Use of botulinum toxin in musculoskeletal painJasvinder A Singh
Arthritis Research & Therapy|April 1, 2014
Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative studyJasvinder A Singh
Annals of the Rheumatic Diseases|January 22, 2015
When gout goes to the heart: does gout equal a cardiovascular disease risk factor?Jasvinder A Singh
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 4, 2020
COVID-19: Science and global health governance under attackJ A Singh
Rheumatology Advances in Practice|January 14, 2022
Disease modification in gout: a qualitative study of gout expert rheumatologistsJasvinder A Singh
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 12, 2021
Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, or Low Back Pain: A National US StudyJasvinder A Singh
Osteoarthritis and Cartilage|November 9, 2023
Does the money matter? Disparities in total joint replacement outcomes by incomeJasvinder A Singh
Annals of the Rheumatic Diseases|July 4, 2020
Response to: 'Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland' by Quills <i>et al</i>Jasvinder A Singh
Expert Opinion on Emerging Drugs|November 7, 2012
Emerging therapies for goutJasvinder A Singh
Rheumatic Diseases Clinics of North America|August 11, 2022
Treatment Guidelines in Rheumatoid ArthritisJasvinder A Singh
Pageof 316